SEC Tracker
Get the app

Acura Pharmaceuticals

Acura Pharmaceuticals missed 10-Q deadline

Late notice: the 10-Q will be filed late

Form
NT 10-Q
Filed
Importance
Notable
  1. Liquidity issues caused late filing
  2. Dependent on loans from Abuse Deterrent Pharma, LLC
  3. No annual reports filed for 2022-2025
  4. No quarterly reports filed for 2022-2026

Written from the NT 10-Q on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Acura Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. America Great Health AAGH
  2. AbbVie ABBV public float $325.1B, Jun 30, 2025
  3. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  4. Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
  5. Arbutus Biopharma ABUS public float $472M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.